Arecor Limited   Report issue

For profit Phase 1
Founded: Little Chesterford United Kingdom (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2019
NCT03959514
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Arecor Limited

Active Ingredients

Drugs in Phase 1 Trials (2)

insulin aspart (Novolog) (4 trials)

insulin human (humulin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 2